Website profile

Via Ritzau

via.ritzau.dk
All articles Clear site filter

Send din pressemeddelelse med det samme Via Ritzau – den direkte linje til medierne.

  • 270articles · 30d
  • 3+ hour agolatest article
  • Aug 18, 2026earliest in window
  • 99%with images
  • 248avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Economy, Business & Finance 228
  • Finance & Business 167
  • News 115
  • Business & Industrial 78
  • Industrial 25
  • Science & Technology 21
  • Health & Wellness 20
  • Medical 18
Site tags

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/5719 > alvotech

Alvotech | Globenewswire

1+ week, 6+ day ago   (309+ words) Under a partnership with Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Alvotech is responsible for the development and manufacturing of AVT80, while Teva is responsible for commercialization. “FDA’s acceptance for review of our BLA for AVT80 is another important milestone for…...

Via Ritzau
via.ritzau.dk > pressemeddelelse > 15/12/5575 > xyra-llc

Xyra, LLC | Globenewswire

1+ week, 6+ day ago   (183+ words) XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation LOS ALTOS, California, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Open-label, dose-escalation study using cardiac rhythm data from implantable and wearable AF monitors allows…...